Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter ... If you are looking for an AI ...

With a market cap of $9.3 billion, Moderna, Inc. (MRNA) is a biotechnology company specializing in the development of messenger RNA (mRNA) therapeutics and vaccines. Known for its COVID-19 vaccine ...

South African global pharmaceutical giant Aspen Pharmacare has found itself caught in Trump tariff-related market volatility, as it witnessed R22 billion being wiped off its JSE market capitalisation ...

Companies with more cash than debt can be financially resilient, but that doesn’t mean they’re all strong investments. Some ...

It’s a much quieter week on the earnings front compared to last week, but we do still have some big names reporting including Palantir Technologies (PLTR), Advanced Micro Devices (AMD), Coinbase (COIN ...

Learn more about whether Catalyst Pharmaceuticals, Inc. or Moderna, Inc. is a better investment based on AAII's A+ Investor ...

We unpack the full scope of the U.S. budget cuts, from canceled clinical trials and stalled drug approvals to mass layoffs ...

The United States has long benefited from an enormous brain gain, with the most talented scientists and engineers around the ...

Learn more about whether Moderna, Inc. or Avidity Biosciences, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Donald Trump and RFK have caused mayhem in the US medical research market. It's clearing a path for Aussie drug trial contractor IDT.